1.44 - 1.45
1.18 - 2.36
61.0K / 1.73M (Avg.)
-18.00 | -0.08
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-78.03%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
110.95%
Positive gross profit growth while 1097.HK is negative. John Neff would see a clear operational edge over the competitor.
No Data
No Data available this quarter, please select a different quarter.
-34.65%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-275.68%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-281.68%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-281.68%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
1.22%
Slight or no buybacks while 1097.HK is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Dividend reduction while 1097.HK stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
63.62%
Positive OCF growth while 1097.HK is negative. John Neff would see this as a clear operational advantage vs. the competitor.
62.89%
Positive FCF growth while 1097.HK is negative. John Neff would see a strong competitive edge in net cash generation.
-99.87%
Negative 10Y revenue/share CAGR while 1097.HK stands at 22.30%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-99.90%
Negative 5Y CAGR while 1097.HK stands at 64.72%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
No Data
No Data available this quarter, please select a different quarter.
-144.81%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-118.30%
Negative 5Y OCF/share CAGR while 1097.HK is at 37.34%. Joel Greenblatt would question the firm’s operational model or cost structure.
No Data
No Data available this quarter, please select a different quarter.
-465.09%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-191.28%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
-100.00%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-17.24%
We have a declining book value while 1097.HK shows 1.77%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-99.63%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.